Dry eye medication use and expenditures

Data from the medical expenditure panel survey 2001 to 2006

Anat Galor, D. Diane Zheng, Kristopher Arheart, Byron L Lam, Victor L Perez Quinones, Kathryn McCollister, Manuel Ocasio, Laura A. McClure, David J Lee

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Purpose: To study dry eye medication use and expenditures from 2001 to 2006 using a nationally representative sample of US adults. Methods: This study retrospectively analyzed dry eye medication use and expenditures of participants of the 2001 to 2006 Medical Expenditure Panel Survey, a nationally representative subsample of the National Health Interview Survey. After adjusting for survey design and for inflation using the 2009 inflation index, data from 147 unique participants aged 18 years or older using the prescription medications Restasis and Blephamide were analyzed. The main outcome measures were dry eye medication use and expenditures from 2001 to 2006. Results: Dry eye medication use and expenditures increased between the years 2001 and 2006, with the mean expenditure per patient per year being $55 in 2001 to 2002 (n = 29), $137 in 2003 to 2004 (n = 32), and $299 in 2005 to 2006 (n = 86). This finding was strongly driven by the introduction of topical cyclosporine emulsion 0.05% (Restasis; Allergan, Irvine, CA). In analysis pooled over all survey years, demographic factors associated with dry eye medication expenditures included gender (female: $244 vs. male: $122, P < 0.0001), ethnicity (non-Hispanic: $228 vs. Hispanic: $106, P < 0.0001), and education (greater than high school: $250 vs. less than high school: $100, P < 0.0001). Conclusions: We found a pattern of increasing dry eye medication use and expenditures from 2001 to 2006. Predictors of higher dry eye medication expenditures included female gender, non-Hispanic ethnicity, and greater than a high school education.

Original languageEnglish
Pages (from-to)1403-1407
Number of pages5
JournalCornea
Volume31
Issue number12
DOIs
StatePublished - Dec 1 2012

Fingerprint

Health Expenditures
Economic Inflation
Education
Surveys and Questionnaires
Health Surveys
Emulsions
Hispanic Americans
Cyclosporine
Prescriptions
Demography
Outcome Assessment (Health Care)
Interviews

Keywords

  • dry eye syndrome
  • expenditures
  • Medical Expenditure Panel Survey
  • MEPS

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Dry eye medication use and expenditures : Data from the medical expenditure panel survey 2001 to 2006. / Galor, Anat; Zheng, D. Diane; Arheart, Kristopher; Lam, Byron L; Perez Quinones, Victor L; McCollister, Kathryn; Ocasio, Manuel; McClure, Laura A.; Lee, David J.

In: Cornea, Vol. 31, No. 12, 01.12.2012, p. 1403-1407.

Research output: Contribution to journalArticle

Galor, Anat ; Zheng, D. Diane ; Arheart, Kristopher ; Lam, Byron L ; Perez Quinones, Victor L ; McCollister, Kathryn ; Ocasio, Manuel ; McClure, Laura A. ; Lee, David J. / Dry eye medication use and expenditures : Data from the medical expenditure panel survey 2001 to 2006. In: Cornea. 2012 ; Vol. 31, No. 12. pp. 1403-1407.
@article{b64d76b73c654b0d897ba9f042b96b1a,
title = "Dry eye medication use and expenditures: Data from the medical expenditure panel survey 2001 to 2006",
abstract = "Purpose: To study dry eye medication use and expenditures from 2001 to 2006 using a nationally representative sample of US adults. Methods: This study retrospectively analyzed dry eye medication use and expenditures of participants of the 2001 to 2006 Medical Expenditure Panel Survey, a nationally representative subsample of the National Health Interview Survey. After adjusting for survey design and for inflation using the 2009 inflation index, data from 147 unique participants aged 18 years or older using the prescription medications Restasis and Blephamide were analyzed. The main outcome measures were dry eye medication use and expenditures from 2001 to 2006. Results: Dry eye medication use and expenditures increased between the years 2001 and 2006, with the mean expenditure per patient per year being $55 in 2001 to 2002 (n = 29), $137 in 2003 to 2004 (n = 32), and $299 in 2005 to 2006 (n = 86). This finding was strongly driven by the introduction of topical cyclosporine emulsion 0.05{\%} (Restasis; Allergan, Irvine, CA). In analysis pooled over all survey years, demographic factors associated with dry eye medication expenditures included gender (female: $244 vs. male: $122, P < 0.0001), ethnicity (non-Hispanic: $228 vs. Hispanic: $106, P < 0.0001), and education (greater than high school: $250 vs. less than high school: $100, P < 0.0001). Conclusions: We found a pattern of increasing dry eye medication use and expenditures from 2001 to 2006. Predictors of higher dry eye medication expenditures included female gender, non-Hispanic ethnicity, and greater than a high school education.",
keywords = "dry eye syndrome, expenditures, Medical Expenditure Panel Survey, MEPS",
author = "Anat Galor and Zheng, {D. Diane} and Kristopher Arheart and Lam, {Byron L} and {Perez Quinones}, {Victor L} and Kathryn McCollister and Manuel Ocasio and McClure, {Laura A.} and Lee, {David J}",
year = "2012",
month = "12",
day = "1",
doi = "10.1097/ICO.0b013e31823cc0b7",
language = "English",
volume = "31",
pages = "1403--1407",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Dry eye medication use and expenditures

T2 - Data from the medical expenditure panel survey 2001 to 2006

AU - Galor, Anat

AU - Zheng, D. Diane

AU - Arheart, Kristopher

AU - Lam, Byron L

AU - Perez Quinones, Victor L

AU - McCollister, Kathryn

AU - Ocasio, Manuel

AU - McClure, Laura A.

AU - Lee, David J

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Purpose: To study dry eye medication use and expenditures from 2001 to 2006 using a nationally representative sample of US adults. Methods: This study retrospectively analyzed dry eye medication use and expenditures of participants of the 2001 to 2006 Medical Expenditure Panel Survey, a nationally representative subsample of the National Health Interview Survey. After adjusting for survey design and for inflation using the 2009 inflation index, data from 147 unique participants aged 18 years or older using the prescription medications Restasis and Blephamide were analyzed. The main outcome measures were dry eye medication use and expenditures from 2001 to 2006. Results: Dry eye medication use and expenditures increased between the years 2001 and 2006, with the mean expenditure per patient per year being $55 in 2001 to 2002 (n = 29), $137 in 2003 to 2004 (n = 32), and $299 in 2005 to 2006 (n = 86). This finding was strongly driven by the introduction of topical cyclosporine emulsion 0.05% (Restasis; Allergan, Irvine, CA). In analysis pooled over all survey years, demographic factors associated with dry eye medication expenditures included gender (female: $244 vs. male: $122, P < 0.0001), ethnicity (non-Hispanic: $228 vs. Hispanic: $106, P < 0.0001), and education (greater than high school: $250 vs. less than high school: $100, P < 0.0001). Conclusions: We found a pattern of increasing dry eye medication use and expenditures from 2001 to 2006. Predictors of higher dry eye medication expenditures included female gender, non-Hispanic ethnicity, and greater than a high school education.

AB - Purpose: To study dry eye medication use and expenditures from 2001 to 2006 using a nationally representative sample of US adults. Methods: This study retrospectively analyzed dry eye medication use and expenditures of participants of the 2001 to 2006 Medical Expenditure Panel Survey, a nationally representative subsample of the National Health Interview Survey. After adjusting for survey design and for inflation using the 2009 inflation index, data from 147 unique participants aged 18 years or older using the prescription medications Restasis and Blephamide were analyzed. The main outcome measures were dry eye medication use and expenditures from 2001 to 2006. Results: Dry eye medication use and expenditures increased between the years 2001 and 2006, with the mean expenditure per patient per year being $55 in 2001 to 2002 (n = 29), $137 in 2003 to 2004 (n = 32), and $299 in 2005 to 2006 (n = 86). This finding was strongly driven by the introduction of topical cyclosporine emulsion 0.05% (Restasis; Allergan, Irvine, CA). In analysis pooled over all survey years, demographic factors associated with dry eye medication expenditures included gender (female: $244 vs. male: $122, P < 0.0001), ethnicity (non-Hispanic: $228 vs. Hispanic: $106, P < 0.0001), and education (greater than high school: $250 vs. less than high school: $100, P < 0.0001). Conclusions: We found a pattern of increasing dry eye medication use and expenditures from 2001 to 2006. Predictors of higher dry eye medication expenditures included female gender, non-Hispanic ethnicity, and greater than a high school education.

KW - dry eye syndrome

KW - expenditures

KW - Medical Expenditure Panel Survey

KW - MEPS

UR - http://www.scopus.com/inward/record.url?scp=84870230391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870230391&partnerID=8YFLogxK

U2 - 10.1097/ICO.0b013e31823cc0b7

DO - 10.1097/ICO.0b013e31823cc0b7

M3 - Article

VL - 31

SP - 1403

EP - 1407

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 12

ER -